𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased Membrane Type 1 Matrix Metalloproteinase Expression from Adenoma to Colon Cancer

✍ Scribed by Sandeep Malhotra; Elliot Newman; David Eisenberg; John Scholes; Rosemary Wieczorek; Paolo Mignatti; Peter Shamamian

Publisher
Springer
Year
2002
Tongue
English
Weight
800 KB
Volume
45
Category
Article
ISSN
0012-3706

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased expression of membrane type 1-
Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma
✍ Tomokazu Yoshizaki; Hiroshi Sato; Yumiko Maruyama; Shigeyuki Murono; Mitsuru Fur πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Background: Three types of membrane type-matrix metalloproteinases (mt-mmps) have been identified as activators of pro-mmp2 (gelatinase a/72-kilodalton type iv collagenase), which is believed to be crucial for tumor invasion and metastasis. mt1-mmp has been shown to be widely expressed in variou

Increased expression of matrix metallopr
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas
✍ Kenichi Ohashi; Tetsuo Nemoto; Kyoichi Nakamura; Ryoichi Nemori πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 497 KB πŸ‘ 1 views

## Background: The 5-year survival rate of patients with submucosal (sm) esophageal carcinoma continues to be much worse than that with intramucosal (m) lesions. the reasons are unclear, but matrix metalloproteinases (mmps) and membrane type matrix metalloproteinases (mt-mmps) are known to be invol

Restricted expression of membrane type 1
Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells
✍ ChristΓ¨le Bisson; Silvia Blacher; Myriam Polette; Jean-FrΓ©dΓ©ric Blanc; Florence πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 457 KB

## Abstract The membrane type‐1 matrix metalloproteinase (MT1‐MMP), a protease originally identified in breast carcinoma, is characterized by its capacity to activate other MMPs (MMP‐2 and MMP‐13) and to degrade extracellular matrix. Our study was undertaken to localize and identify the MT1‐MMP exp